BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23088210)

  • 1. NADPH oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia.
    Abais JM; Zhang C; Xia M; Liu Q; Gehr TW; Boini KM; Li PL
    Antioxid Redox Signal; 2013 May; 18(13):1537-48. PubMed ID: 23088210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia.
    Zhang C; Boini KM; Xia M; Abais JM; Li X; Liu Q; Li PL
    Hypertension; 2012 Jul; 60(1):154-62. PubMed ID: 22647887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of endogenously produced reactive oxygen species to the activation of podocyte NLRP3 inflammasomes in hyperhomocysteinemia.
    Abais JM; Xia M; Li G; Gehr TW; Boini KM; Li PL
    Free Radic Biol Med; 2014 Feb; 67():211-20. PubMed ID: 24140862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemia.
    Abais JM; Xia M; Li G; Chen Y; Conley SM; Gehr TWB; Boini KM; Li PL
    J Biol Chem; 2014 Sep; 289(39):27159-27168. PubMed ID: 25138219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of guanine nucleotide exchange factor Vav2 to NLRP3 inflammasome activation in mouse podocytes during hyperhomocysteinemia.
    Conley SM; Abais-Battad JM; Yuan X; Zhang Q; Boini KM; Li PL
    Free Radic Biol Med; 2017 May; 106():236-244. PubMed ID: 28193546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-to-mesenchymal transition in podocytes mediated by activation of NADPH oxidase in hyperhomocysteinemia.
    Zhang C; Xia M; Boini KM; Li CX; Abais JM; Li XX; Laperle LA; Li PL
    Pflugers Arch; 2011 Sep; 462(3):455-67. PubMed ID: 21647593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox signaling via lipid raft clustering in homocysteine-induced injury of podocytes.
    Zhang C; Hu JJ; Xia M; Boini KM; Brimson C; Li PL
    Biochim Biophys Acta; 2010 Apr; 1803(4):482-91. PubMed ID: 20036696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NADPH oxidase-induced NALP3 inflammasome activation is driven by thioredoxin-interacting protein which contributes to podocyte injury in hyperglycemia.
    Gao P; He FF; Tang H; Lei CT; Chen S; Meng XF; Su H; Zhang C
    J Diabetes Res; 2015; 2015():504761. PubMed ID: 25834832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Action of Anandamide and Its COX-2 Metabolite against l-Homocysteine-Induced NLRP3 Inflammasome Activation and Injury in Podocytes.
    Li G; Xia M; Abais JM; Boini K; Li PL; Ritter JK
    J Pharmacol Exp Ther; 2016 Jul; 358(1):61-70. PubMed ID: 27189966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rac1 GTPase Inhibition Blocked Podocyte Injury and Glomerular Sclerosis during Hyperhomocysteinemia via Suppression of Nucleotide-Binding Oligomerization Domain-Like Receptor Containing Pyrin Domain 3 Inflammasome Activation.
    Zhang Q; Conley SM; Li G; Yuan X; Li PL
    Kidney Blood Press Res; 2019; 44(4):513-532. PubMed ID: 31266025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury.
    Li G; Chen Z; Bhat OM; Zhang Q; Abais-Battad JM; Conley SM; Ritter JK; Li PL
    J Lipid Res; 2017 Jun; 58(6):1080-1090. PubMed ID: 28404641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91phox gene.
    Zhang C; Hu JJ; Xia M; Boini KM; Brimson CA; Laperle LA; Li PL
    Free Radic Biol Med; 2010 Apr; 48(8):1109-17. PubMed ID: 20116427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocyte-specific silencing of acid sphingomyelinase gene to abrogate hyperhomocysteinemia-induced NLRP3 inflammasome activation and glomerular inflammation.
    Huang D; Kidd JM; Zou Y; Wu X; Li N; Gehr TWB; Li PL; Li G
    Am J Physiol Renal Physiol; 2024 Jun; 326(6):F988-F1003. PubMed ID: 38634138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of hyperhomocysteinemia-induced inflammasome activation and glomerular sclerosis by NLRP3 gene deletion.
    Xia M; Conley SM; Li G; Li PL; Boini KM
    Cell Physiol Biochem; 2014; 34(3):829-41. PubMed ID: 25171193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of inflammasomes in podocyte injury of mice on the high fat diet: Effects of ASC gene deletion and silencing.
    Boini KM; Xia M; Abais JM; Li G; Pitzer AL; Gehr TW; Zhang Y; Li PL
    Biochim Biophys Acta; 2014 May; 1843(5):836-45. PubMed ID: 24508291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of TLR4 attenuates high glucose-induced podocyte injury via the NALP3/ASC/Caspase-1 signaling pathway.
    Liu Y; Xu Z; Ma F; Jia Y; Wang G
    Biomed Pharmacother; 2018 Nov; 107():1393-1401. PubMed ID: 30257355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective role of growth hormone against hyperhomocysteinemia-induced glomerular injury.
    Li C; Xia M; Abais JM; Liu X; Li N; Boini KM; Li PL
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Jun; 386(6):551-61. PubMed ID: 23529346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of membrane raft redox signalling to visfatin-induced inflammasome activation and podocyte injury.
    Koka S; Surineni S; Singh GB; Boini KM
    Aging (Albany NY); 2023 Nov; 15(22):12738-12748. PubMed ID: 38032896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal by growth hormone of homocysteine-induced epithelial-to-mesenchymal transition through membrane raft-redox signaling in podocytes.
    Li CX; Xia M; Han WQ; Li XX; Zhang C; Boini KM; Liu XC; Li PL
    Cell Physiol Biochem; 2011; 27(6):691-702. PubMed ID: 21691087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of lipid raft redox signalling platforms in glomerular endothelial cells: an early event of homocysteine-induced glomerular injury.
    Yi F; Jin S; Zhang F; Xia M; Bao JX; Hu J; Poklis JL; Li PL
    J Cell Mol Med; 2009 Sep; 13(9B):3303-14. PubMed ID: 20196779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.